Web Results

blogs.harvard.edu/billofhealth/tag/n-w-et-al-v-sanofi-pasteur-msd

Jul 2, 2017 ... This is likely to be the case with the European Court of Justice (ECJ) decision on vaccine manufacturers' liability, N.W. et al. v. Sanofi Pasteur MSD, C‑621/15. Popular press reacted to this decision with sharp criticism that included unsubstantiated assertions about the European law of products liability, ...

www.law360.com/articles/7971/drug-cos-hit-with-plavix-antitrust-class-action

Aug 1, 2006 ... Pharmaceutical giants Bristol-Myers Squibb Co., Sanofi-Aventis and Apotex Corp . were served with two antitrust class actions on Monday over their ... 1:06-cv-503 in the United States District Court for the Southern District of Ohio and Parker v. ... The Plavix patent case is Sanofi-Synthelabo et al. v.

dockets.justia.com/browse/state-louisiana/noscat-3

Heppner v. Lone Star Transportation, LLC et al. Filed: December 15, 2017 as 2: 2017cv01627. Defendant: Lone Star Transportation, LLC, Daseke Lone Star, Inc. , James French, Jr. Plaintiff: Brandon Heppner. Cause Of Action: Diversity- Personal Injury. Court: Fifth Circuit › Louisiana › Louisiana Western District Court.

www.jpml.uscourts.gov/sites/jpml/files/Hearing_Order-5-25-2017.pdf

Apr 13, 2017 ... Section A of this Schedule lists the matters designated for oral argument and includes all actions encompassed by Motion(s) for transfer filed pursuant to. Rules 6.1 and 6.2. Any party waiving oral argument pursuant to Rule 11.1(d) need not attend the Hearing Session. •. Section B of this Schedule lists the ...

www.aauw.org/resource/parker-v-in-high-school-athletic-assoc

The primary issue in the case centers on whether or not the discriminatory scheduling of girls' basketball games on non-prime time days violates Title IX of the Educational Amendment of 1972. Read more »

blogs.orrick.com/antitrust/2016/05/19/third-circuit-rejects-drug-manufacturers-single-product-bundling-claim-but-prescription-for-the-future-is-unclear

May 19, 2016 ... You know what they say: one man's price is another man's bundle. No? Well maybe they should, after this recent decision out of the Third Circuit in Eisai, Inc. v . Sanofi Aventis U.S., LLC involving allegedly exclusionary discounting. The court ultimately found Sanofi's conduct was not unlawful. But the ...

arbitrationblog.kluwerarbitration.com/2013/06/26/sanofi-aventis-deutschland-gmbh-v-genentech-inc-freedom-to-choose

Jun 26, 2013 ... In a judgment dated 10 May 2013 (Sanofi-Aventis Deutschland GmbH v. Genentech, Inc., Appeal No 2012-1454) the United States Court of Appeals for the Federal Circuit (the 'CAFC') affirmed a first-instance decision refusing the grant of an injunction preventing Sanofi-Aventis Deutschland GmbH ...

www.almcms.com/contrib/content/uploads/sites/292/2017/07/Talc-removals-Pradaxa-ruling.pdf

vs. ) Case No. 4:16 CV 1942 CDP. ) BOEHRINGER INGELHEIM. ) PHARMACEUTICALS, INC., et al., ). ) Defendants. ) MEMORANDUM AND ORDER .... See also Addelson v. Sanofi, No. 4:16-CV-1277 ERW, 2016 WL. 6216124 (E.D. Mo. Oct. 25, 2016) (personal jurisdiction is the more straightforward issue and should be ...

www.717madisonplace.com/?m=201009

Sep 28, 2010 ... 2010-1216. DCT. COMBINED TACTICAL V DEFENSE TECH. [argued]. 2010- 3101. MSPB. CAHILL V DEFENSE. [on the briefs]. 2010-5139. CFC. PARKER V US. [on the briefs] ... Inc., et al. v. Medtronic Sofamor Danek USA, Inc. et al., 2009- 1538 (Fed. Cir. ..... Aventis Pharma Deutschland v. Lupin, Ltd., 499 ...